Back to LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc.

All insider transactions

3 transactions

DateMoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Mar 27, 2026Buy
Common StockGeorge Jeffrey P.
Director
+5,592$8.92$49.9K5,592low
Mar 27, 2026Buy
Common StockSchimmelpennink Evert B.
CEO
+28,089$8.95$251.4K77,289medium
Mar 27, 2026BuyCommon StockChevallard Daniel R.
Executive
+7,500$8.57$64.3K12,886medium
← PrevPage 1 of 1Next →